hospitalhealthcare3h
Lung cancer pathway insights from Dr Zaheer Mangera part 2: neoadjuvant therapy
Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestProvidence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean ...
Nature10y
Cetuximab plus chemotherapy in patients with advanced NSCLC
The EGFR pathway has an important role in modulating angiogenesis, metastasis, cell survival and proliferation (Figure 1); therefore, inhibition of this pathway is being explored for therapeutic ...
Medscape10d
Epidermal Growth Factor Receptor as a Target in Pancreatic Cancer
pathway. Overexpression of EGFR receptor may be detected in up to 90% of pancreatic tumors and ErbB- 2 expression in up to 21% of pancreatic tumors. Blockade of the activity of these receptors ...
2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment
ProKidney’s Rilparencel shows promise for CKD patients, with Phase 2 data expected in 2025. Learn why PROK stock is a “Buy” ...
Healio8d
VIDEO: Definition of EGFR-mutated lung cancer continues to expand
Yeah, so the EGFR mutation lung cancer field has really expanded. We usually think about EGFR as the classical mutation, deletion 19 and 858R mutation. But in the last, I will say, five to 10 ...
Healio1mon
Topical gel shows promise in treating cutaneous events from EGFR inhibitor cancer therapy
The company is currently developing HT-001 with intentions of submitting a new drug application via the 505(b)(2) regulatory pathway, according to the company website.